methotrexate IBD
Selected indexed studies
- AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. (Gastroenterology, 2024) [PMID:39572132]
- GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis. (Cell, 2022) [PMID:35021065]
- Methotrexate in IBD: the return of the prodigal son. (J Crohns Colitis, 2015) [PMID:25814523]
_Worker-drafted node — pending editorial review._
Connections
methotrexate IBD is a side effect of
Sources
- A comprehensive review and update on Crohn's disease. (2018) pubmed
- AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. (2024) pubmed
- Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. (2014) pubmed
- GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis. (2022) pubmed
- Methotrexate in IBD: the return of the prodigal son. (2015) pubmed
- Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. (2017) pubmed
- The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBD. (2023) pubmed
- Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review. (2021) pubmed
- Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies. (2024) pubmed
- Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study. (2022) pubmed